Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVSEF) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $446.32.

  • Novartis Ag's EPS (Basic) fell 1956.65% to $446.32 in Q4 2025 from the same period last year, while for Dec 2025 it was $446.32, marking a year-over-year decrease of 1956.65%. This contributed to the annual value of $1939.5 for FY2025, which is 384.38% down from last year.
  • Novartis Ag's EPS (Basic) amounted to $446.32 in Q4 2025, which was down 1956.65% from $0.0 recorded in Q3 2025.
  • Novartis Ag's EPS (Basic)'s 5-year high stood at $2388.5 during Q1 2024, with a 5-year trough of $0.0 in Q1 2021.
  • For the 5-year period, Novartis Ag's EPS (Basic) averaged around $534.38, with its median value being $100.73 (2022).
  • As far as peak fluctuations go, Novartis Ag's EPS (Basic) crashed by 10000.0% in 2021, and later soared by 7380738739713.97% in 2022.
  • Novartis Ag's EPS (Basic) (Quarter) stood at $0.0 in 2021, then skyrocketed by 721325138.36% to $54.51 in 2022, then skyrocketed by 2494.86% to $1414.5 in 2023, then tumbled by 60.77% to $554.9 in 2024, then decreased by 19.57% to $446.32 in 2025.
  • Its last three reported values are $446.32 in Q4 2025, $0.0 for Q3 2025, and $0.0 during Q2 2025.